Effect of tablet splitting on serum cholesterol concentrations

To evaluate the effects of tablet splitting on low-density lipoprotein (LDL) cholesterol and total cholesterol values in patients taking simvastatin and atorvastatin. A retrospective chart review of total cholesterol and LDL cholesterol values of patients instructed to split simvastatin or atorvasta...

Full description

Saved in:
Bibliographic Details
Published inThe Annals of pharmacotherapy Vol. 36; no. 2; p. 205
Main Authors Duncan, Megan C, Castle, Sharon S, Streetman, Daniel S
Format Journal Article
LanguageEnglish
Published United States 01.02.2002
Subjects
Online AccessGet more information

Cover

Loading…
Abstract To evaluate the effects of tablet splitting on low-density lipoprotein (LDL) cholesterol and total cholesterol values in patients taking simvastatin and atorvastatin. A retrospective chart review of total cholesterol and LDL cholesterol values of patients instructed to split simvastatin or atorvastatin between January 1999 and November 2000. Veterans Affairs Medical Center in Huntington, WV. Patients were included if they were taking simvastatin or atorvastatin with regular lipid management and follow-up laboratory results. Patients were required to remain on the same milligram-per-day dose at least 6-8 weeks before and after tablet-splitting initiation and have cholesterol values drawn at least 6 weeks after initiation of both whole-tablet and half-tablet dosing. Patients were excluded if they had a triglyceride level > 400 mg/dL or were noncompliant on the basis of pharmacy records and provider notes. MEASUREMENT OUTCOMES: The primary end points were changes in total cholesterol and LDL cholesterol values before and after the patient was switched to half-tablet therapy. The overall results for this review demonstrated no statistically significant increase in total cholesterol and LDL cholesterol concentrations. Total cholesterol and LDL cholesterol values actually decreased from presplitting to postsplitting, p = 0.017 and p = 0.003, respectively. The investigation showed that half-tablet dosing was as effective as whole-tablet dosing. The program will be continued as a part of quality patient care at the Huntington Veterans Affairs Medical Center.
AbstractList To evaluate the effects of tablet splitting on low-density lipoprotein (LDL) cholesterol and total cholesterol values in patients taking simvastatin and atorvastatin. A retrospective chart review of total cholesterol and LDL cholesterol values of patients instructed to split simvastatin or atorvastatin between January 1999 and November 2000. Veterans Affairs Medical Center in Huntington, WV. Patients were included if they were taking simvastatin or atorvastatin with regular lipid management and follow-up laboratory results. Patients were required to remain on the same milligram-per-day dose at least 6-8 weeks before and after tablet-splitting initiation and have cholesterol values drawn at least 6 weeks after initiation of both whole-tablet and half-tablet dosing. Patients were excluded if they had a triglyceride level > 400 mg/dL or were noncompliant on the basis of pharmacy records and provider notes. MEASUREMENT OUTCOMES: The primary end points were changes in total cholesterol and LDL cholesterol values before and after the patient was switched to half-tablet therapy. The overall results for this review demonstrated no statistically significant increase in total cholesterol and LDL cholesterol concentrations. Total cholesterol and LDL cholesterol values actually decreased from presplitting to postsplitting, p = 0.017 and p = 0.003, respectively. The investigation showed that half-tablet dosing was as effective as whole-tablet dosing. The program will be continued as a part of quality patient care at the Huntington Veterans Affairs Medical Center.
Author Castle, Sharon S
Streetman, Daniel S
Duncan, Megan C
Author_xml – sequence: 1
  givenname: Megan C
  surname: Duncan
  fullname: Duncan, Megan C
  organization: Veterans Affairs Medical Center, Huntington, WV, USA
– sequence: 2
  givenname: Sharon S
  surname: Castle
  fullname: Castle, Sharon S
– sequence: 3
  givenname: Daniel S
  surname: Streetman
  fullname: Streetman, Daniel S
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11847935$$D View this record in MEDLINE/PubMed
BookMark eNo1z7tOwzAUgGEPRfQCAy-A_AIp59hOYi9IVVUuUiUWmCvbOaZBiR3F7sDbMwDTv33Sv2aLmCIxdoewRanqBzudt7gTUi7YCqGBCoSGJVvn_AUABoW5ZktErVoj6xV7PIRAvvAUeLFuoMLzNPSl9PGTp8gzzZeR-3MaKBea08B9ip5imW3pU8w37CrYIdPtXzfs4-nwvn-pjm_Pr_vdsfJSiVIForZT0hskbMHXQrSm076GIImc905jY7TrHAJpj7WV1qpWKildAwqM2LD7X3e6uJG60zT3o52_T_8j4gfcx0n2
CitedBy_id crossref_primary_10_1016_j_clinthera_2011_02_009
crossref_primary_10_1111_tmi_12309
crossref_primary_10_1590_S0103_21002011000100011
crossref_primary_10_1007_s12272_011_0717_8
crossref_primary_10_1177_107424840300800205
crossref_primary_10_3390_ph16010008
crossref_primary_10_1016_j_amjcard_2005_02_019
crossref_primary_10_1007_s40005_012_0030_7
crossref_primary_10_1177_001857870403900807
crossref_primary_10_1177_001857870303800513
crossref_primary_10_1097_01_AOG_0000365943_34401_28
crossref_primary_10_1016_j_ijpharm_2007_08_041
crossref_primary_10_1007_s40272_016_0193_1
crossref_primary_10_1016_j_clinthera_2015_08_015
crossref_primary_10_15406_ppij_2022_10_00359
crossref_primary_10_4140_TCP_n_2012_421
crossref_primary_10_1111_j_1759_8893_2010_00020_x
crossref_primary_10_37667_pk_2002_57
crossref_primary_10_1592_phco_22_13_1110_33518
crossref_primary_10_1016_j_ijpharm_2016_12_032
crossref_primary_10_52494_FTLZ3502
crossref_primary_10_3399_BJGPO_2022_0001
crossref_primary_10_1111_j_1365_2648_2010_05477_x
crossref_primary_10_3389_fped_2021_747499
crossref_primary_10_1016_j_jsps_2011_12_009
crossref_primary_10_1016_j_ejps_2003_10_018
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1345/aph.1A233
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
ExternalDocumentID 11847935
Genre Journal Article
GeographicLocations West Virginia
GeographicLocations_xml – name: West Virginia
GroupedDBID ---
-TM
.GJ
01A
0R~
0VX
1CY
23M
39C
4.4
53G
54M
5GY
5RE
6J9
6PF
AABMB
AACKU
AACMV
AACTG
AADTT
AADUE
AAEWN
AAGGD
AAGMC
AAJIQ
AAJOX
AAJPV
AAKGS
AAMGE
AANSI
AAPEO
AAQQT
AAQXH
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAWTL
AAXOT
AAYOK
AAYTG
AAZBJ
ABAWP
ABCCA
ABDWY
ABEIX
ABFWQ
ABHKI
ABJIS
ABJNI
ABKRH
ABLUO
ABOCM
ABPGX
ABPNF
ABQKF
ABQXT
ABRHV
ABVFX
ABVVC
ABYTW
ACARO
ACDSZ
ACDXX
ACFEJ
ACFMA
ACFYK
ACGBL
ACGFO
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLHI
ACLZU
ACOFE
ACOXC
ACROE
ACSBE
ACSIQ
ACTQU
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADEIA
ADMPF
ADNBR
ADRRZ
ADTBJ
ADUKL
ADZZY
AECGH
AECVZ
AEDTQ
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEUIJ
AEWDL
AEWHI
AEXFG
AEXNY
AFEET
AFFNX
AFKBI
AFKRG
AFMOU
AFQAA
AFUIA
AGKLV
AGNHF
AGWFA
AHJOV
AIGRN
AIIQI
AIOMO
AIZAD
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
AJXAJ
ALKWR
ALMA_UNASSIGNED_HOLDINGS
ALTZF
AMCVQ
ANDLU
ARTOV
AUTPY
AUVAJ
AYAKG
B8M
BBRGL
BDDNI
BKIIM
BKSCU
BPACV
BSEHC
BWJAD
CBRKF
CDWPY
CFDXU
CGR
CORYS
CQQTX
CS3
CUTAK
CUY
CVF
DB0
DC-
DC.
DC0
DD-
DD0
DE-
DE.
DF0
DN0
DO-
DOPDO
DV7
EBS
ECM
EIF
EJD
EMOBN
F5P
FHBDP
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HZ~
J5H
J8X
JCYGO
K.F
L7B
LSO
M4V
NPM
O9-
P.9
P.B
P2P
Q1R
ROL
S01
SCNPE
SFC
SHG
SJN
SPQ
SPV
THW
UDS
WH7
YCJ
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
ZXP
ID FETCH-LOGICAL-c342t-fee7d43c91e170c52279d8c50f3eebccb81698bdb10e8c15a3aa473433b604092
ISSN 1060-0280
IngestDate Sat Sep 28 07:36:30 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c342t-fee7d43c91e170c52279d8c50f3eebccb81698bdb10e8c15a3aa473433b604092
PMID 11847935
ParticipantIDs pubmed_primary_11847935
PublicationCentury 2000
PublicationDate 2002-02-01
PublicationDateYYYYMMDD 2002-02-01
PublicationDate_xml – month: 02
  year: 2002
  text: 2002-02-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Annals of pharmacotherapy
PublicationTitleAlternate Ann Pharmacother
PublicationYear 2002
SSID ssj0009129
Score 1.8719555
Snippet To evaluate the effects of tablet splitting on low-density lipoprotein (LDL) cholesterol and total cholesterol values in patients taking simvastatin and...
SourceID pubmed
SourceType Index Database
StartPage 205
SubjectTerms Atorvastatin Calcium
Cholesterol - blood
Cholesterol, LDL - blood
Cross-Over Studies
Drug Costs
Female
Heptanoic Acids - administration & dosage
Heptanoic Acids - economics
Heptanoic Acids - pharmacology
Humans
Male
Middle Aged
Pyrroles - administration & dosage
Pyrroles - economics
Pyrroles - pharmacology
Retrospective Studies
Simvastatin - administration & dosage
Simvastatin - economics
Simvastatin - pharmacology
Tablets
West Virginia
Title Effect of tablet splitting on serum cholesterol concentrations
URI https://www.ncbi.nlm.nih.gov/pubmed/11847935
Volume 36
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JS8QwGA0uFy_ivksO4mWmmjTptLkIIooIiocRvA1JmiqCnQHrQX-9X5a2M6PiAqWUpg1p3-ORfMn3gtBBapKMGCqiONMk4ipJIlHkKtKCCJ0SaaRf5XvTu7zjV_fJfbtnq8suqdSRfv8yr-Q_qMI9wNVmyf4B2aZSuAHXgC-cAWE4_wrjYD1sp_ltBlTVeYEuZVjIXHagCa_PHStvzg1haI1ASr8Ys43SPbVsab2UR8HPupq0HIDOrvbx0mvzALrQBFjPpJ0sdoFUeNMqUBO4cZPeIcrq09lDYR1piOvFyY04kh6J7FTsuHp6-5LAknhcCl069WeJZty6WcjR4xE9jb0JxhhUo2eHFQx7bMgv-bl0yi27LppFs2lmFe_GRm9qE2bqdq1rviM4TUGLjpv2WBfZUMfUSMP1OPpLaDEMFfCpx30ZzZhyBR3eemzeurjfps69dPEhvm1dyN9W0YknBx4W2JMDN-TAwxI7cuAxcuBJcqyhu4vz_tllFDbLiDTjcRUVxqQ5Z1pQQ1OiE-sMmWc6IQUzRmmtMtoTmcoVJSbTNJFMSp4yzpjqgZCLeB3NlcPSbCJMJOU0VULnRcElM0LBIeB5w2Oak3wLbfj_Mhh5R5RB_ce2vy3ZQQstpXbRfAGENnvQn6vUvgPpA6RxTAo
link.rule.ids 786
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+tablet+splitting+on+serum+cholesterol+concentrations&rft.jtitle=The+Annals+of+pharmacotherapy&rft.au=Duncan%2C+Megan+C&rft.au=Castle%2C+Sharon+S&rft.au=Streetman%2C+Daniel+S&rft.date=2002-02-01&rft.issn=1060-0280&rft.volume=36&rft.issue=2&rft.spage=205&rft_id=info:doi/10.1345%2Faph.1A233&rft_id=info%3Apmid%2F11847935&rft_id=info%3Apmid%2F11847935&rft.externalDocID=11847935
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1060-0280&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1060-0280&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1060-0280&client=summon